CTKB
CTKB
NASDAQ · Life Sciences Tools & Services

Cytek Biosciences Inc

$4.61
-0.31 (-6.30%)
As of May 10, 10:19 PM ET ·
Analyst Consensus
Buy
10
Analysts
Moderate
Coverage
Buy 7 70%
Hold 3 30%
Sell 0 0%
Price Target
Analyst Price Target +1,123.0% upside
Low Target $40.67
Average Target $56.38
High Target $70.69
Current Price $4.61
Current
$4.61
Target
$56.38
$40.67 $56.38 avg $70.69
Scenario Analysis
Bear Case
$40.67
782.2%
Low target
Base Case
$56.38
+1,123.0%
Avg target
Bull Case
$70.69
+1,433.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$6.18
-25.4% from high
52-Week Low
$2.37
+94.5% from low
Target vs 52W High
$56.38
+812.3% vs high
Next Earnings Report
May 13, 2026 · After Market Close
Today
EPS Est: $-0.08
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 88% $369.21 -18.4%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -5.1%
WAT
Waters Corp
Buy 28 57% $189.60 -45.5%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -42.0%
IQV
Iqvia Holdings Inc
Strong Buy 31 87% $82.96 -52.2%
MTD
Mettler-Toledo International
Hold 21 48% $170.43 -84.2%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -57.7%
ILMN
Illumina Inc
Hold 28 54% $169.36 +18.8%